{"filing":{"accession_number":"0001193125-26-239977","cik":"0001856725","ticker":"RANI","company_name":"Rani Therapeutics Holdings, Inc.","form":"8-K","filing_date":"2026-05-27","report_date":null,"primary_document":"d312913d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1856725/000119312526239977/d312913d8k.htm"},"events":[{"id":8705,"run_id":7643,"accession_number":"0001193125-26-239977","anchor_item_number":"8.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"Rani entered into a securities purchase agreement on May 26, 2026, to issue 12,476,637 shares of Class A common stock and 6,214,953 pre-funded warrants for approximately $20.0 million in gross proceeds. This is a classic dilutive equity issuance to institutional investors, disclosed under Item 8.01 (Other Events). The transaction includes lock-up agreements and a 90-day lock-up on further issuances, typical of PIPE-like offerings that materially dilute existing shareholders.","company_name":"Rani Therapeutics Holdings, Inc.","ticker":"RANI","filing_date":"2026-05-27","form":"8-K","submitted_at":null,"items":[{"id":1866,"accession_number":"0001193125-26-239977","item_number":"8.01","item_title":"Other Events","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Rani entered into a securities purchase agreement on May 26, 2026, to issue 12,476,637 shares of Class A common stock and 6,214,953 pre-funded warrants for approximately $20.0 million in gross proceeds. This is a classic dilutive equity issuance to institutional investors, disclosed under Item 8.01 (Other Events). The transaction includes lock-up agreements and a 90-day lock-up on further issuances, typical of PIPE-like offerings that materially dilute existing shareholders.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-28T02:12:04.843578+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":1866,"accession_number":"0001193125-26-239977","item_number":"8.01","item_title":"Other Events","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Rani entered into a securities purchase agreement on May 26, 2026, to issue 12,476,637 shares of Class A common stock and 6,214,953 pre-funded warrants for approximately $20.0 million in gross proceeds. This is a classic dilutive equity issuance to institutional investors, disclosed under Item 8.01 (Other Events). The transaction includes lock-up agreements and a 90-day lock-up on further issuances, typical of PIPE-like offerings that materially dilute existing shareholders.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-28T02:12:04.843578+00:00","company_name":"Rani Therapeutics Holdings, Inc.","ticker":"RANI","filing_date":"2026-05-27"}]}